Nizhny Novgorod faces silent HPV epidemic as officials push vaccination

Nizhny Novgorod faces silent HPV epidemic as officials push vaccination

Bar chart showing the proportion of cancers caused by HPV in the United States with accompanying explanatory text.

Nizhny Novgorod faces silent HPV epidemic as officials push vaccination

Up to 90% of people in Nizhny Novgorod Region will contract human papillomavirus (HPV) at some stage in life. Yet most infections go unnoticed, as the virus often shows no symptoms. Health officials are now pushing for better prevention and wider vaccination to reduce risks linked to the common infection. HPV spreads widely, but the body usually clears the infection without treatment. In rare cases, persistent infections can lead to health complications. Currently, the only way to confirm HPV is through PCR testing, though mass screening remains unavailable in Nizhny Novgorod Region.

Doctors stress that vaccination is the best defence. Since January 2026, the HPV vaccine has been approved for adults and authorised for children aged nine and older. Childhood immunisation is particularly encouraged as an effective way to prevent future infections. Russia's first domestic HPV vaccine production facility opened in Kirov Region in autumn 2025. Once output increases, the vaccine is set to join the country's National Immunization Schedule. However, no reliable data exists yet on how HPV rates in Russia compare to other nations with similar vaccination programmes.

Public awareness campaigns are now a priority alongside vaccination efforts. With most infections resolving naturally, health authorities focus on reducing long-term risks. The push for wider immunisation aims to lower HPV-related health issues in the coming years.

Neueste Nachrichten